img

Global Cabozantinib Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cabozantinib Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Cabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc.
Cabozantinib report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cabozantinib market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medullary Thyroid Cancer Treatment and Second Line Treatment for Renal Cell Carcinoma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cabozantinib industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cabozantinib key manufacturers include Exelixis, Tecoland Corporation, Fermion Oy, Sun Pharmaceutical Industries Limit, MSN Laboratories Pvt Ltd, Shanghai Hope Chem, Hetero Drugs Limited, Huateng Pharmaceutical Co. and Bio Nova Pharmaceuticals Private Limited, etc. Exelixis, Tecoland Corporation, Fermion Oy are top 3 players and held % sales share in total in 2022.
Cabozantinib can be divided into Capsule and Tablet, etc. Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Cabozantinib is widely used in various fields, such as Medullary Thyroid Cancer Treatment and Second Line Treatment for Renal Cell Carcinoma, etc. Medullary Thyroid Cancer Treatment provides greatest supports to the Cabozantinib industry development. In 2022, global % sales of Cabozantinib went into Medullary Thyroid Cancer Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cabozantinib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Exelixis
Tecoland Corporation
Fermion Oy
Sun Pharmaceutical Industries Limit
MSN Laboratories Pvt Ltd
Shanghai Hope Chem
Hetero Drugs Limited
Huateng Pharmaceutical Co.
Bio Nova Pharmaceuticals Private Limited
AlchemyPharm
Segment by Type
Capsule
Tablet

Segment by Application


Medullary Thyroid Cancer Treatment
Second Line Treatment for Renal Cell Carcinoma

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cabozantinib market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cabozantinib, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cabozantinib industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cabozantinib in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cabozantinib introduction, etc. Cabozantinib Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cabozantinib market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Cabozantinib Market Overview
1.1 Cabozantinib Product Overview
1.2 Cabozantinib Market Segment by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Global Cabozantinib Market Size by Type
1.3.1 Global Cabozantinib Market Size Overview by Type (2018-2034)
1.3.2 Global Cabozantinib Historic Market Size Review by Type (2018-2024)
1.3.3 Global Cabozantinib Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cabozantinib Sales Breakdown by Type (2018-2024)
1.4.2 Europe Cabozantinib Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Cabozantinib Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Cabozantinib Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Cabozantinib Sales Breakdown by Type (2018-2024)
2 Global Cabozantinib Market Competition by Company
2.1 Global Top Players by Cabozantinib Sales (2018-2024)
2.2 Global Top Players by Cabozantinib Revenue (2018-2024)
2.3 Global Top Players by Cabozantinib Price (2018-2024)
2.4 Global Top Manufacturers Cabozantinib Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cabozantinib Market Competitive Situation and Trends
2.5.1 Cabozantinib Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Cabozantinib Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cabozantinib as of 2022)
2.7 Date of Key Manufacturers Enter into Cabozantinib Market
2.8 Key Manufacturers Cabozantinib Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cabozantinib Status and Outlook by Region
3.1 Global Cabozantinib Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Cabozantinib Historic Market Size by Region
3.2.1 Global Cabozantinib Sales in Volume by Region (2018-2024)
3.2.2 Global Cabozantinib Sales in Value by Region (2018-2024)
3.2.3 Global Cabozantinib Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Cabozantinib Forecasted Market Size by Region
3.3.1 Global Cabozantinib Sales in Volume by Region (2024-2034)
3.3.2 Global Cabozantinib Sales in Value by Region (2024-2034)
3.3.3 Global Cabozantinib Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Cabozantinib by Application
4.1 Cabozantinib Market Segment by Application
4.1.1 Medullary Thyroid Cancer Treatment
4.1.2 Second Line Treatment for Renal Cell Carcinoma
4.2 Global Cabozantinib Market Size by Application
4.2.1 Global Cabozantinib Market Size Overview by Application (2018-2034)
4.2.2 Global Cabozantinib Historic Market Size Review by Application (2018-2024)
4.2.3 Global Cabozantinib Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cabozantinib Sales Breakdown by Application (2018-2024)
4.3.2 Europe Cabozantinib Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Cabozantinib Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Cabozantinib Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Cabozantinib Sales Breakdown by Application (2018-2024)
5 North America Cabozantinib by Country
5.1 North America Cabozantinib Historic Market Size by Country
5.1.1 North America Cabozantinib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Cabozantinib Sales in Volume by Country (2018-2024)
5.1.3 North America Cabozantinib Sales in Value by Country (2018-2024)
5.2 North America Cabozantinib Forecasted Market Size by Country
5.2.1 North America Cabozantinib Sales in Volume by Country (2024-2034)
5.2.2 North America Cabozantinib Sales in Value by Country (2024-2034)
6 Europe Cabozantinib by Country
6.1 Europe Cabozantinib Historic Market Size by Country
6.1.1 Europe Cabozantinib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Cabozantinib Sales in Volume by Country (2018-2024)
6.1.3 Europe Cabozantinib Sales in Value by Country (2018-2024)
6.2 Europe Cabozantinib Forecasted Market Size by Country
6.2.1 Europe Cabozantinib Sales in Volume by Country (2024-2034)
6.2.2 Europe Cabozantinib Sales in Value by Country (2024-2034)
7 Asia-Pacific Cabozantinib by Region
7.1 Asia-Pacific Cabozantinib Historic Market Size by Region
7.1.1 Asia-Pacific Cabozantinib Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Cabozantinib Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Cabozantinib Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Cabozantinib Forecasted Market Size by Region
7.2.1 Asia-Pacific Cabozantinib Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Cabozantinib Sales in Value by Region (2024-2034)
8 Latin America Cabozantinib by Country
8.1 Latin America Cabozantinib Historic Market Size by Country
8.1.1 Latin America Cabozantinib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Cabozantinib Sales in Volume by Country (2018-2024)
8.1.3 Latin America Cabozantinib Sales in Value by Country (2018-2024)
8.2 Latin America Cabozantinib Forecasted Market Size by Country
8.2.1 Latin America Cabozantinib Sales in Volume by Country (2024-2034)
8.2.2 Latin America Cabozantinib Sales in Value by Country (2024-2034)
9 Middle East and Africa Cabozantinib by Country
9.1 Middle East and Africa Cabozantinib Historic Market Size by Country
9.1.1 Middle East and Africa Cabozantinib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Cabozantinib Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Cabozantinib Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Cabozantinib Forecasted Market Size by Country
9.2.1 Middle East and Africa Cabozantinib Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Cabozantinib Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Exelixis
10.1.1 Exelixis Company Information
10.1.2 Exelixis Introduction and Business Overview
10.1.3 Exelixis Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Exelixis Cabozantinib Products Offered
10.1.5 Exelixis Recent Development
10.2 Tecoland Corporation
10.2.1 Tecoland Corporation Company Information
10.2.2 Tecoland Corporation Introduction and Business Overview
10.2.3 Tecoland Corporation Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Tecoland Corporation Cabozantinib Products Offered
10.2.5 Tecoland Corporation Recent Development
10.3 Fermion Oy
10.3.1 Fermion Oy Company Information
10.3.2 Fermion Oy Introduction and Business Overview
10.3.3 Fermion Oy Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Fermion Oy Cabozantinib Products Offered
10.3.5 Fermion Oy Recent Development
10.4 Sun Pharmaceutical Industries Limit
10.4.1 Sun Pharmaceutical Industries Limit Company Information
10.4.2 Sun Pharmaceutical Industries Limit Introduction and Business Overview
10.4.3 Sun Pharmaceutical Industries Limit Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sun Pharmaceutical Industries Limit Cabozantinib Products Offered
10.4.5 Sun Pharmaceutical Industries Limit Recent Development
10.5 MSN Laboratories Pvt Ltd
10.5.1 MSN Laboratories Pvt Ltd Company Information
10.5.2 MSN Laboratories Pvt Ltd Introduction and Business Overview
10.5.3 MSN Laboratories Pvt Ltd Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.5.4 MSN Laboratories Pvt Ltd Cabozantinib Products Offered
10.5.5 MSN Laboratories Pvt Ltd Recent Development
10.6 Shanghai Hope Chem
10.6.1 Shanghai Hope Chem Company Information
10.6.2 Shanghai Hope Chem Introduction and Business Overview
10.6.3 Shanghai Hope Chem Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Shanghai Hope Chem Cabozantinib Products Offered
10.6.5 Shanghai Hope Chem Recent Development
10.7 Hetero Drugs Limited
10.7.1 Hetero Drugs Limited Company Information
10.7.2 Hetero Drugs Limited Introduction and Business Overview
10.7.3 Hetero Drugs Limited Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Hetero Drugs Limited Cabozantinib Products Offered
10.7.5 Hetero Drugs Limited Recent Development
10.8 Huateng Pharmaceutical Co.
10.8.1 Huateng Pharmaceutical Co. Company Information
10.8.2 Huateng Pharmaceutical Co. Introduction and Business Overview
10.8.3 Huateng Pharmaceutical Co. Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Huateng Pharmaceutical Co. Cabozantinib Products Offered
10.8.5 Huateng Pharmaceutical Co. Recent Development
10.9 Bio Nova Pharmaceuticals Private Limited
10.9.1 Bio Nova Pharmaceuticals Private Limited Company Information
10.9.2 Bio Nova Pharmaceuticals Private Limited Introduction and Business Overview
10.9.3 Bio Nova Pharmaceuticals Private Limited Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Bio Nova Pharmaceuticals Private Limited Cabozantinib Products Offered
10.9.5 Bio Nova Pharmaceuticals Private Limited Recent Development
10.10 AlchemyPharm
10.10.1 AlchemyPharm Company Information
10.10.2 AlchemyPharm Introduction and Business Overview
10.10.3 AlchemyPharm Cabozantinib Sales, Revenue and Gross Margin (2018-2024)
10.10.4 AlchemyPharm Cabozantinib Products Offered
10.10.5 AlchemyPharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cabozantinib Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cabozantinib Industrial Chain Analysis
11.4 Cabozantinib Market Dynamics
11.4.1 Cabozantinib Industry Trends
11.4.2 Cabozantinib Market Drivers
11.4.3 Cabozantinib Market Challenges
11.4.4 Cabozantinib Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cabozantinib Distributors
12.3 Cabozantinib Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Capsule
Table 2. Major Company of Tablet
Table 3. Global Cabozantinib Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Cabozantinib Sales by Type (2018-2024) & (Tons)
Table 5. Global Cabozantinib Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Cabozantinib Sales by Type (2018-2024) & (US& Million)
Table 7. Global Cabozantinib Market Share in Value by Type (2018-2024)
Table 8. Global Cabozantinib Price by Type (2018-2024) & (US$/Kg)
Table 9. Global Cabozantinib Sales by Type (2024-2034) & (Tons)
Table 10. Global Cabozantinib Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Cabozantinib Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Cabozantinib Sales Market Share in Value by Type (2024-2034)
Table 13. Global Cabozantinib Price by Type (2024-2034) & (US$/Kg)
Table 14. North America Cabozantinib Sales by Type (2018-2024) & (Tons)
Table 15. North America Cabozantinib Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Cabozantinib Sales (Tons) by Type (2018-2024)
Table 17. Europe Cabozantinib Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Cabozantinib Sales (Tons) by Type (2018-2024)
Table 19. Asia-Pacific Cabozantinib Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Cabozantinib Sales (Tons) by Type (2018-2024)
Table 21. Latin America Cabozantinib Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Cabozantinib Sales (Tons) by Type (2018-2024)
Table 23. Middle East and Africa Cabozantinib Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Cabozantinib Sales by Company (2018-2024) & (Tons)
Table 25. Global Cabozantinib Sales Share by Company (2018-2024)
Table 26. Global Cabozantinib Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Cabozantinib Revenue Share by Company (2018-2024)
Table 28. Global Market Cabozantinib Price by Company (2018-2024) & (US$/Kg)
Table 29. Global Cabozantinib Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Cabozantinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cabozantinib as of 2022)
Table 32. Date of Key Manufacturers Enter into Cabozantinib Market
Table 33. Key Manufacturers Cabozantinib Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Cabozantinib Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Cabozantinib Sales by Region (2018-2024) & (Tons)
Table 37. Global Cabozantinib Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Cabozantinib Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Cabozantinib Sales Market Share in Value by Region (2018-2024)
Table 40. Global Cabozantinib Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 41. Global Cabozantinib Sales by Region (2024-2034) & (Tons)
Table 42. Global Cabozantinib Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Cabozantinib Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Cabozantinib Sales Market Share in Value by Region (2024-2034)
Table 45. Global Cabozantinib Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2034)
Table 46. Global Cabozantinib Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Cabozantinib Sales by Application (2018-2024) & (Tons)
Table 48. Global Cabozantinib Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Cabozantinib Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Cabozantinib Sales Market Share in Value by Application (2018-2024)
Table 51. Global Cabozantinib Price by Application (2018-2024) & (US$/Kg)
Table 52. Global Cabozantinib Sales by Application (2024-2034) & (Tons)
Table 53. Global Cabozantinib Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Cabozantinib Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Cabozantinib Sales Market Share in Value by Application (2024-2034)
Table 56. Global Cabozantinib Price by Application (2024-2034) & (US$/Kg)
Table 57. North America Cabozantinib Sales by Application (2018-2024) (Tons)
Table 58. North America Cabozantinib Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Cabozantinib Sales by Application (2018-2024) (Tons)
Table 60. Europe Cabozantinib Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Cabozantinib Sales by Application (2018-2024) (Tons)
Table 62. Asia-Pacific Cabozantinib Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Cabozantinib Sales by Application (2018-2024) (Tons)
Table 64. Latin America Cabozantinib Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Cabozantinib Sales by Application (2018-2024) (Tons)
Table 66. Middle East and Africa Cabozantinib Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Cabozantinib Sales by Country (2018-2024) & (Tons)
Table 68. North America Cabozantinib Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Cabozantinib Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Cabozantinib Sales Market Share in Value by Country (2018-2024)
Table 71. North America Cabozantinib Sales by Country (2024-2034) & (Tons)
Table 72. North America Cabozantinib Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Cabozantinib Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Cabozantinib Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Cabozantinib Sales by Country (2018-2024) & (Tons)
Table 76. Europe Cabozantinib Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Cabozantinib Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Cabozantinib Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Cabozantinib Sales by Country (2024-2034) & (Tons)
Table 80. Europe Cabozantinib Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Cabozantinib Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Cabozantinib Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Cabozantinib Sales by Region (2018-2024) & (Tons)
Table 84. Asia-Pacific Cabozantinib Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Cabozantinib Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Cabozantinib Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Cabozantinib Sales by Region (2024-2034) & (Tons)
Table 88. Asia-Pacific Cabozantinib Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Cabozantinib Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Cabozantinib Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Cabozantinib Sales by Country (2018-2024) & (Tons)
Table 92. Latin America Cabozantinib Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Cabozantinib Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Cabozantinib Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Cabozantinib Sales by Country (2024-2034) & (Tons)
Table 96. Latin America Cabozantinib Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Cabozantinib Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Cabozantinib Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Cabozantinib Sales by Country (2018-2024) & (Tons)
Table 100. Middle East and Africa Cabozantinib Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Cabozantinib Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Cabozantinib Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Cabozantinib Sales by Country (2024-2034) & (Tons)
Table 104. Middle East and Africa Cabozantinib Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Cabozantinib Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Cabozantinib Sales Market Share in Value by Country (2024-2034)
Table 107. Exelixis Company Information
Table 108. Exelixis Introduction and Business Overview
Table 109. Exelixis Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 110. Exelixis Cabozantinib Product
Table 111. Exelixis Recent Development
Table 112. Tecoland Corporation Company Information
Table 113. Tecoland Corporation Introduction and Business Overview
Table 114. Tecoland Corporation Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 115. Tecoland Corporation Cabozantinib Product
Table 116. Tecoland Corporation Recent Development
Table 117. Fermion Oy Company Information
Table 118. Fermion Oy Introduction and Business Overview
Table 119. Fermion Oy Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 120. Fermion Oy Cabozantinib Product
Table 121. Fermion Oy Recent Development
Table 122. Sun Pharmaceutical Industries Limit Company Information
Table 123. Sun Pharmaceutical Industries Limit Introduction and Business Overview
Table 124. Sun Pharmaceutical Industries Limit Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 125. Sun Pharmaceutical Industries Limit Cabozantinib Product
Table 126. Sun Pharmaceutical Industries Limit Recent Development
Table 127. MSN Laboratories Pvt Ltd Company Information
Table 128. MSN Laboratories Pvt Ltd Introduction and Business Overview
Table 129. MSN Laboratories Pvt Ltd Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 130. MSN Laboratories Pvt Ltd Cabozantinib Product
Table 131. MSN Laboratories Pvt Ltd Recent Development
Table 132. Shanghai Hope Chem Company Information
Table 133. Shanghai Hope Chem Introduction and Business Overview
Table 134. Shanghai Hope Chem Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 135. Shanghai Hope Chem Cabozantinib Product
Table 136. Shanghai Hope Chem Recent Development
Table 137. Hetero Drugs Limited Company Information
Table 138. Hetero Drugs Limited Introduction and Business Overview
Table 139. Hetero Drugs Limited Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 140. Hetero Drugs Limited Cabozantinib Product
Table 141. Hetero Drugs Limited Recent Development
Table 142. Huateng Pharmaceutical Co. Company Information
Table 143. Huateng Pharmaceutical Co. Introduction and Business Overview
Table 144. Huateng Pharmaceutical Co. Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 145. Huateng Pharmaceutical Co. Cabozantinib Product
Table 146. Huateng Pharmaceutical Co. Recent Development
Table 147. Bio Nova Pharmaceuticals Private Limited Company Information
Table 148. Bio Nova Pharmaceuticals Private Limited Introduction and Business Overview
Table 149. Bio Nova Pharmaceuticals Private Limited Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 150. Bio Nova Pharmaceuticals Private Limited Cabozantinib Product
Table 151. Bio Nova Pharmaceuticals Private Limited Recent Development
Table 152. AlchemyPharm Company Information
Table 153. AlchemyPharm Introduction and Business Overview
Table 154. AlchemyPharm Cabozantinib Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 155. AlchemyPharm Cabozantinib Product
Table 156. AlchemyPharm Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Cabozantinib Market Trends
Table 160. Cabozantinib Market Drivers
Table 161. Cabozantinib Market Challenges
Table 162. Cabozantinib Market Restraints
Table 163. Cabozantinib Distributors List
Table 164. Cabozantinib Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Cabozantinib Product Picture
Figure 2. Global Cabozantinib Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Cabozantinib Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Cabozantinib Sales Status and Outlook (2018-2034) & (Tons)
Figure 5. Product Picture of Capsule
Figure 6. Global Capsule Sales YoY Growth (2018-2034) & (Tons)
Figure 7. Product Picture of Tablet
Figure 8. Global Tablet Sales YoY Growth (2018-2034) & (Tons)
Figure 9. Global Cabozantinib Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Cabozantinib Sales Market Share by Type in 2022 & 2034
Figure 11. North America Cabozantinib Sales Market Share in Volume by Type in 2022
Figure 12. North America Cabozantinib Sales Market Share in Value by Type in 2022
Figure 13. Europe Cabozantinib Sales Market Share in Volume by Type in 2022
Figure 14. Europe Cabozantinib Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Cabozantinib Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Cabozantinib Sales Market Share in Value by Type in 2022
Figure 17. Latin America Cabozantinib Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Cabozantinib Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Cabozantinib Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Cabozantinib Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Cabozantinib Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Cabozantinib Revenue in 2022
Figure 23. Cabozantinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Medullary Thyroid Cancer Treatment
Figure 25. Global Medullary Thyroid Cancer Treatment Sales YoY Growth (2018-2034) & (Tons)
Figure 26. Product Picture of Second Line Treatment for Renal Cell Carcinoma
Figure 27. Global Second Line Treatment for Renal Cell Carcinoma Sales YoY Growth (2018-2034) & (Tons)
Figure 28. Global Cabozantinib Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Cabozantinib Sales Market Share by Application in 2022 & 2034
Figure 30. North America Cabozantinib Sales Market Share in Volume by Application in 2022
Figure 31. North America Cabozantinib Sales Market Share in Value by Application in 2022
Figure 32. Europe Cabozantinib Sales Market Share in Volume by Application in 2022
Figure 33. Europe Cabozantinib Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Cabozantinib Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Cabozantinib Sales Market Share in Value by Application in 2022
Figure 36. Latin America Cabozantinib Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Cabozantinib Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Cabozantinib Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Cabozantinib Manufacturing Cost Structure
Figure 41. Cabozantinib Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries